Agilent Technologies Share Price (NYSE: A)

$125.69

▲

0.73

(0.58%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Agilent Technologies Stock chart to analyse performance

Agilent Technologies stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$124.21
Today's High:$126.10
$125.69
1.18%
Downside
Day's Volatility :1.5%
Upside
0.33%
52 Weeks Low:$96.43
52 Weeks High:$153.84
$125.69
23.28%
Downside
52 Weeks Volatility :37.32%
Upside
18.3%

Agilent Technologies Stock Returns

Period	Agilent Technologies Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	13.16%	3.6%	0.0%
6 Months	-0.53%	-7.7%	0.0%
1 Year	-9.57%	-12.6%	0.0%
3 Years	-1.84%	8.4%	-3.0%

Agilent Technologies Inc. Key Stats

Check Agilent Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$124.96
Open	$125.3
Today's High	$126.1
Today's Low	$124.21
Market Capitalization	$35.7B
Today's Volume	$1.8M
52 Week High	$153.84
52 Week Low	$96.43
Revenue TTM	$6.8B
EBITDA	$1.8B
Earnings Per Share (EPS)	$4.29
PE Ratio	29.29
Dividend Yield	0.78%
Profit Margin	17.97%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	19.88%

Stock Returns calculator for Agilent Technologies Stock including INR - Dollar returns

The Agilent Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Agilent Technologies investment value today

Current value as on today

₹95,735

Returns

₹4,265

(-4.27%)

Returns from Agilent Technologies Stock

₹9,550 (-9.55%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Agilent Technologies Stock

Period: Aug 1, 2025 to Aug 31, 2025. Change in 30 Days versus previous period

Search interest for Agilent Technologies Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Agilent Technologies Stock

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	75728	8318.72	2.34%
Aditya Birla Sun Life International Equity Fund Direct Plan Growth	1600	-119.46	0.70%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	447	0.00	0.27%
Motilal Oswal S&P 500 Index Fund Direct Growth	2305	-10.99	0.06%

Global Institutional Holdings in Agilent Technologies Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.99%
BlackRock Inc
9.14%
Massachusetts Financial Services Company
4.66%
State Street Corp
4.45%
Wellington Management Company LLP
3.15%
T. Rowe Price Investment Management,Inc.
2.88%

Analyst Recommendation on Agilent Technologies Stock

Rating

Trend

Buy

50%Buy

46%Hold

3%Sell

Based on 26 Wall street analysts offering stock ratings for Agilent Technologies(by analysts ranked 0 to 5 stars)

Agilent Technologies Share Price Target

What analysts predicted

Upside of 9.93%

Target:

$138.17

Current:

$125.69

Agilent Technologies share price target is $138.17, a slight Upside of 9.93% compared to current price of $125.69 as per analysts' prediction.

Agilent Technologies Stock Insights

Price Movement
In the last 7 days, A stock has moved up by 5.5%
Increasing Revenue
Agilent Technologies Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $1.66 billion to $1.73 billion, reflecting an average quarter-on-quarter growth of 4.0%.
Increasing Net Profit
Agilent Technologies Inc. has shown positive performance in its profit trends over the last two quarters. The company's net profit increased from $215.0 million to $336.0 million, representing an average growth of 36.0% each quarter.
A vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 46.3%
A vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 84.6% return, outperforming this stock by 87.1%
Price to Sales
Agilent Technologies Inc. has a Price-to-Sales Ratio of 5.3, meaning that investors are willing to pay $5.3 for every $1 of sales the company generates. In contrast, Idexx Laboratories, Inc. has a higher Price-to-Sales Ratio of 13.0, indicating that investors value its sales more than those of Agilent.

Agilent Technologies Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$5.2B	↑ 5.07%
Net Income	$1.1B	↑ 238.92%
Net Profit Margin	20.74%	↑ 14.31%

	FY20	Y/Y Change
Revenue	$5.3B	↑ 3.41%
Net Income	$719.0M	↓ 32.87%
Net Profit Margin	13.47%	↓ 7.27%

	FY21	Y/Y Change
Revenue	$6.3B	↑ 18.36%
Net Income	$1.2B	↑ 68.29%
Net Profit Margin	19.15%	↑ 5.68%

	FY22	Y/Y Change
Revenue	$6.8B	↑ 8.37%
Net Income	$1.3B	↑ 3.64%
Net Profit Margin	18.31%	↓ 0.84%

	FY23	Y/Y Change
Revenue	$6.8B	↓ 0.22%
Net Income	$1.2B	↓ 1.12%
Net Profit Margin	18.15%	↓ 0.16%

	FY24	Y/Y Change
Revenue	$6.5B	↓ 4.73%
Net Income	$1.3B	↑ 3.95%
Net Profit Margin	19.8%	↑ 1.65%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Revenue	$1.6B	↓ 5.13%
Net Income	$308.0M	↓ 11.49%
Net Profit Margin	19.58%	↓ 1.41%

	Q3 FY24	Q/Q Change
Revenue	$1.6B	↑ 0.32%
Net Income	$282.0M	↓ 8.44%
Net Profit Margin	17.87%	↓ 1.71%

	Q4 FY24	Q/Q Change
Revenue	$1.7B	↑ 7.79%
Net Income	$351.0M	↑ 24.47%
Net Profit Margin	20.63%	↑ 2.76%

	Q1 FY25	Q/Q Change
Revenue	$1.7B	↓ 1.18%
Net Income	$318.0M	↓ 9.4%
Net Profit Margin	18.92%	↓ 1.71%

	Q2 FY25	Q/Q Change
Revenue	$1.7B	↓ 0.77%
Net Income	$215.0M	↓ 32.39%
Net Profit Margin	12.89%	↓ 6.03%

	Q3 FY25	Q/Q Change
Revenue	$1.7B	↑ 4.2%
Net Income	$336.0M	↑ 56.28%
Net Profit Margin	19.33%	↑ 6.44%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$2.8B	↑ 4.39%

	FY20	Y/Y Change
Profit	$2.8B	↑ 1.14%

	FY21	Y/Y Change
Profit	$3.4B	↑ 20.09%

	FY22	Y/Y Change
Profit	$3.7B	↑ 9.25%

	FY23	Y/Y Change
Profit	$3.5B	↓ 6.9%

	FY24	Y/Y Change
Profit	$3.5B	↑ 2.02%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Profit	$856.0M	↓ 5.73%

	Q3 FY24	Q/Q Change
Profit	$855.0M	↓ 0.12%

	Q4 FY24	Q/Q Change
Profit	$916.0M	↑ 7.13%

	Q1 FY25	Q/Q Change
Profit	$899.0M	↓ 1.86%

	Q2 FY25	Q/Q Change
Profit	$866.0M	↓ 3.67%

	Q3 FY25	Q/Q Change
Profit	$914.0M	↑ 5.54%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.0B	↓ 6.07%
Investing Cash Flow	$-1.6B	↑ 125.85%
Financing Cash Flow	$-299.0M	↓ 62.48%

	FY20	Y/Y Change
Operating Cash Flow	$921.0M	↓ 9.79%
Investing Cash Flow	$-147.0M	↓ 90.75%
Financing Cash Flow	$-717.0M	↑ 139.8%

	FY21	Y/Y Change
Operating Cash Flow	$1.5B	↑ 61.24%
Investing Cash Flow	$-749.0M	↑ 409.52%
Financing Cash Flow	$-696.0M	↓ 2.93%

	FY22	Y/Y Change
Operating Cash Flow	$1.3B	↓ 11.65%
Investing Cash Flow	$-338.0M	↓ 54.87%
Financing Cash Flow	$-1.4B	↑ 97.13%

	FY23	Y/Y Change
Operating Cash Flow	$1.8B	↑ 35.06%
Investing Cash Flow	$-310.0M	↓ 8.28%
Financing Cash Flow	$-930.0M	↓ 32.22%

	FY24	Y/Y Change
Operating Cash Flow	$1.8B	↓ 1.19%
Investing Cash Flow	$-1.3B	↑ 305.81%
Financing Cash Flow	$-752.0M	↓ 19.14%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

	Q2 FY24	Q/Q Change
Operating Cash Flow	$333.0M	↓ 31.34%
Investing Cash Flow	$-109.0M	↑ 14.74%
Financing Cash Flow	$-291.0M	↑ 21.25%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$452.0M	↑ 35.74%
Investing Cash Flow	$-100.0M	↓ 8.26%
Financing Cash Flow	$-246.0M	↓ 15.46%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$481.0M	↑ 6.42%
Investing Cash Flow	$-954.0M	↑ 854.0%
Financing Cash Flow	$25.0M	↓ 110.16%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$431.0M	↓ 10.4%
Investing Cash Flow	$-94.0M	↓ 90.15%
Financing Cash Flow	$-180.0M	↓ 820.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$221.0M	↓ 48.72%
Investing Cash Flow	$-114.0M	↑ 21.28%
Financing Cash Flow	$-116.0M	↓ 35.56%

	Q3 FY25	Q/Q Change
Operating Cash Flow	$362.0M	↑ 63.8%
Investing Cash Flow	$-96.0M	↓ 15.79%
Financing Cash Flow	$-219.0M	↑ 88.79%

Agilent Technologies Technicals Summary

Sell

Neutral

Buy

Agilent Technologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Agilent Technologies Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Agilent Technologies Inc.	9.42%	-0.53%	-9.57%	-1.84%	21.5%
Idexx Laboratories, Inc.	-5.23%	48.02%	37.97%	88.2%	59.26%
Thermo Fisher Scientific, Inc.	5.6%	-5.9%	-18.75%	-9.35%	11.71%
Danaher Corp.	4.23%	0.06%	-22.11%	-23.61%	-1.98%
Iqvia Holdings Inc.	4.41%	3.22%	-23.31%	-7.94%	12.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Agilent Technologies Inc.	29.29	29.29	1.96	5.57	0.2	0.08	0.01	22.46
Idexx Laboratories, Inc.	53.75	53.75	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.5	28.5	2.01	22.5	0.13	0.05	0.0	133.77
Danaher Corp.	43.7	43.7	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.09	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Agilent Technologies Inc.	Buy	$35.7B	21.5%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	59.26%	53.75	24.41%
Thermo Fisher Scientific, Inc.	Buy	$186.1B	11.71%	28.5	15.24%
Danaher Corp.	Buy	$147.4B	-1.98%	43.7	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	12.41%	27.61	7.88%

Agilent Technologies Dividend announcements

Agilent Technologies Dividends September, 2025
In the quarter ending September,2025. Agilent Technologies has declared dividend of $0.25

About Agilent Technologies Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Organization	Agilent Technologies
Employees	18000
CEO	Mr. Padraig McDonnell
Industry	Health Technology

Key Management of Agilent Technologies Inc.

Name	Title
Mr. Padraig McDonnell	CEO, President & Director
Dr. Simon May	SVP & President of LDG
Mr. Rodney Gonsalves	Interim CFO, Principal Accounting Officer, VP & Corporate Controller
Mr. August Specht Ph.D.	Senior VP & Chief Technology Officer
Mr. Parmeet Ahuja	Vice President of Investor Relations
Mr. Bret M. DiMarco	Senior VP, Chief Legal Officer, & Secretary
Mr. Frederick Schwarz	SVP, Chief Strategy & Corporate Development Officer
Ms. Meghan A. Henson	Senior VP & Chief Human Resources Officer
Ms. Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe
Ms. Jenipher E. Dalton	Senior VP, Chief Quality & Regulatory Officer

Important FAQs about investing in A Stock from India :

What is Agilent Technologies share price today?

Agilent Technologies share price today is $125.69 as on August 30, 2025 at 1:29 am IST at the close of the market. Agilent Technologies share today touched a day high of $126.10 and a low of $124.21.

What is the 52 week high and 52 week low for Agilent Technologies share?

Agilent Technologies share touched a 52 week high of $153.84 and a 52 week low of $96.43. Agilent Technologies stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $125.69, lower by 18.3% versus the 52 week high.

How to invest in Agilent Technologies Stock (A) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Agilent Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agilent Technologies Shares that will get you 0.0119 shares as per Agilent Technologies share price of $125.69 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Agilent Technologies Stock (A) from India?

Indian investors can start investing in Agilent Technologies (A) shares with as little as ₹88.286 or $1 (as of September 01, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Agilent Technologies stock (as per the Rupee-Dollar exchange rate as on September 01, 2025). Based on Agilent Technologies share’s latest price of $125.69 as on August 30, 2025 at 1:29 am IST, you will get 0.0796 shares of Agilent Technologies. Learn more about fractional shares .

What are the returns that Agilent Technologies has given to Indian investors in the last 5 years?

Agilent Technologies stock has given 21.5% share price returns and 20.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?